Benign lipomatous neoplasm of skin and subcutaneous tissue of other sites
ICD-10 D17.39 is a billable code used to indicate a diagnosis of benign lipomatous neoplasm of skin and subcutaneous tissue of other sites.
D17.39 refers to benign lipomatous neoplasms that occur in the skin and subcutaneous tissue at sites other than the specified locations in the ICD-10 classification. These neoplasms are characterized by the proliferation of adipose tissue and are typically non-cancerous. They can present as soft, movable masses under the skin and may vary in size. While most lipomas are asymptomatic and do not require treatment, they can sometimes cause discomfort or cosmetic concerns, prompting surgical removal. Surveillance for these neoplasms is generally minimal unless there are changes in size, shape, or symptoms, which may warrant further evaluation to rule out malignancy. Although benign, it is essential to monitor these lesions, as rare cases of atypical lipomatous tumors can arise, necessitating a careful clinical assessment.
Detailed description of the lesion, including size, location, and any symptoms.
Evaluation of a patient presenting with a soft tissue mass, assessment of lipoma for surgical removal.
Ensure accurate coding based on the specific site and characteristics of the lipomatous neoplasm.
Operative reports detailing the excision procedure and pathology results.
Surgical removal of a lipoma due to size or discomfort.
Document the reason for surgery and any findings during the procedure.
Used when excising a lipoma for symptomatic relief.
Operative report detailing the excision and pathology results.
Ensure the excision is documented as benign to support the use of D17.39.
Most benign lipomatous neoplasms are asymptomatic, but they can cause discomfort if they compress surrounding tissues or if they grow large.
Surveillance is typically minimal unless there are changes in size, shape, or symptoms, which may require further evaluation.
While benign lipomas are non-cancerous, there are rare cases where atypical lipomatous tumors can arise, necessitating careful monitoring.
